Immuneering
IMRX
IMRX
49 hedge funds and large institutions have $176M invested in Immuneering in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+15
Holders Change %
+44.12%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
19
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
|
$42.6M |
| 2 |
2
BlackRock
New York
|
$24.6M |
| 3 |
3
Bank of Montreal
Toronto,
Ontario, Canada
|
$8M |
| 4 |
4
Goldman Sachs
New York
|
$4.96M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$3.38M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$563K | -57,949 | Closed |
|
52
Jane Street
New York
| – | -$452K | -46,571 | Closed |
|
|
YIH
53
Y-Intercept (HK)
Hong Kong
| – | -$108K | -11,114 | Closed |
|
54
UBS Group
Zurich,
Switzerland
| – | -$26.3K | -2,713 | Closed |
|
55
Man Group
London,
United Kingdom
| – | -$118K | – | – |
|